Search Results for "metoclopramide"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for metoclopramide. Results 11 to 20 of 25 total matches.
See also: Reglan
Sumatriptan for Migraine
The Medical Letter on Drugs and Therapeutics • Oct 02, 1992 (Issue 880)
and more effective in relieving pain than 900 mg of aspirin plus 10 mg of metoclopramide (Reglan ...
Sumatriptan (soo ma trip' tan; Imitrex - Glaxo), a serotonin (5-HT) agonist, is now available in Canada and may soon be available in the USA for oral or parenteral treatment of migraine headache. The parenteral formulation is designed for patients to inject themselves subcutaneously. Sumatriptan is not recommended for prophylactic use.
Apomorphine (Apokyn) for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Jan 17, 2005 (Issue 1200)
of consciousness. Dopamine
antagonists such as prochlorperazine (Compazine) or
metoclopramide (Reglan, and others ...
Apomorphine (Apokyn - Mylan/Bertek), an injected non-ergot dopamine agonist, was recently approved by the FDA for intermittent subcutaneous (SC) treatment of hypomobility ("off" episodes) in patients with advanced Parkinson's disease. It has been available in Europe for many years.
Pergolide And Selegiline For Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Sep 08, 1989 (Issue 800)
such as metoclopramide (Reglan;
and others) or domperidone (Motilium in Canada) (JD Parkes, Clin Neuropharmacol, 9:517 ...
Levodopa combined with carbidopa (Sinemet) is the treatment of choice for Parkinson's disease (Medical Letter, 30:113, 1988). After prolonged treatment, however, the symptoms of the disease often become difficult to manage. The benefit from each dose becomes shorter (the 'wearing-off' effect), sudden fluctuations occur between mobility and immobility (the 'on-off' phenomenon), and abnormal involuntary movements (dyskinesias) may become frequent. The dopamine agonist bromocriptine (Parlodel) can ameliorate some of these effects. Two new drugs, pergolide (Permax - Lilly), another dopamine...
Atovaquone/Proguanil (Malarone) for Malaria
The Medical Letter on Drugs and Therapeutics • Nov 27, 2000 (Issue 1093)
is unknown.
DRUG INTERACTIONS — Co-administration of tetracycline, metoclopramide (Reglan,and
others ...
A fixed-dose combination of atovaquone and proguanil hydrochloride has been approved by the FDA for oral prophylaxis and treatment of malaria due to Plasmodium falciparum, including choloroquine-resistant strains.
Onapgo — An Apomorphine Subcutaneous Infusion for Parkinson's Disease
The Medical Letter on Drugs and Therapeutics • Jul 21, 2025 (Issue 1733)
or metoclopramide (Reglan,
and others), which are used for treatment of nausea
and vomiting, may decrease ...
Onapgo (Supernus), a solution for continuous
subcutaneous infusion containing the dopamine
agonist apomorphine, has been approved by the FDA
for treatment of motor fluctuations in adults with
advanced Parkinson's disease (PD). Subcutaneously
injected apomorphine (Apokyn, and generics) has
been available for intermittent use for years. Vyalev, a
foscarbidopa/foslevodopa solution for subcutaneous
infusion, was approved in 2024 for the same indication.
Med Lett Drugs Ther. 2025 Jul 21;67(1733):116-8 doi:10.58347/tml.2025.1733d | Show Introduction Hide Introduction
Bromocriptine (Cycloset) for Type 2 Diabetes
The Medical Letter on Drugs and Therapeutics • Dec 13, 2010 (Issue 1353)
,
concurrent use of a dopamine receptor antagonist
such as metoclopramide (Reglan, and others ...
The FDA has approved a new tablet formulation of
bromocriptine mesylate (Cycloset – VeroScience) for
treatment of type 2 diabetes in adults. Bromocriptine
(Parlodel, and others) is an ergot-derived dopamine
agonist that has been used for more than 20 years to
treat hyperprolactinemia, acromegaly, Parkinson’s disease
and restless leg syndrome.
Atypical Antipsychotics in the Elderly
The Medical Letter on Drugs and Therapeutics • Aug 01, 2005 (Issue 1214)
Cipro Ciprofloxacin clozapine Clozaril Luvox metoclopramide Mexiletine Reglan Risperdal risperidone ...
The FDA has reported that 5106 elderly patients with dementia treated with atypical (second generation) antipsychotics in 17 randomized controlled trials had a higher mortality rate (4.5% vs. 2.6%) than those receiving placebo. Most of the deaths were due to cardiovascular and infectious causes (such as pneumonia). The drugs used in the trials were aripiprazole (Abilify), olanzapine (Zyprexa), quetiapine (Seroquel), and risperidone (Risperdal). As the increase in mortality was considered a class effect, the FDA advisory also included ziprasidone (Geodon), clozapine (Clozaril) and the...
Drugs That May Cause Psychiatric Symptoms
The Medical Letter on Drugs and Therapeutics • Dec 15, 2008 (Issue 1301)
, anxiety, encephalopathy In children and adults
Metoclopramide (Reglan*) Depression, anxiety, mania ...
Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.
Click here to view the free full article.
Click here to view the free full article.
Nabilone (Cesamet) for Chemotherapy-Induced Nausea and Vomiting
The Medical Letter on Drugs and Therapeutics • Dec 04, 2006 (Issue 1249)
, and others), and dronabinol was as
effective as metoclopramide (Reglan, and others).
4 ...
Nabilone, an oral synthetic cannabinoid similar to delta-9-tetrahydrocannabinol (THC), the active ingredient in marijuana, has recently been reintroduced to the US market (Cesamet - Valeant) after a 17-year absence. The previous manufacturer discontinued marketing of the drug for commercial reasons. Nabilone is classified as a Schedule II controlled substance.
Drugs for Migraine
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023 (Issue 1678)
, but pretreatment
with or concurrent use of an antiemetic drug such
as metoclopramide can reduce GI adverse ...
An oral nonopioid analgesic is often sufficient for
acute treatment of mild to moderate migraine pain
without severe nausea or vomiting. A triptan is the
drug of choice for treatment of moderate to severe
migraine in most patients without vascular disease.
Treatment of pain when it is still mild to moderate in
intensity improves headache response and reduces
the risk of recurrence.
Med Lett Drugs Ther. 2023 Jun 12;65(1678):89-96 doi:10.58347/tml.2023.1678a | Show Introduction Hide Introduction